Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Designing a Diagnostic Tablet for Point-of-Care Hepatitis C Virus (HCV) Detection using Quantum Dot Barcodes.
EF 2017-18
Résumé
Hepatitis C virus (HCV) can cause chronic hepatitis C, a treatable infectious disease that continues to contribute to liver-related illness and death. In 2011, there were over 245 000 Canadians living with chronic hepatitis C. Unfortunately, only 20% of individuals with HCV are thought to be diagnosed, as access to HCV testing is limited. Standard HCV tests are slow, costly, labour intensive, and require extensive user training, making them unsuitable for use in resource-poor areas where they are needed most critically. Early diagnosis, however, allows patients to prevent complications and obtain treatment earlier. In order to determine which HCV treatment is best suited for a patient, doctors must know the type of HCV causing the infection. Here I propose a design for a low-cost, easy-to-use diagnostic test that can identify the type and quantity of HCV using a single tablet.
In my project I will use nanoparticles, materials 1-100nm in size, to detect different types of HCV. Nanoparticles colour coded for HCV type will be used in combination to identify multiple types of HCV in the same test. These nanoparticles will be encased in a tablet-similar to drug tablets that dissolve in liquids. A tablet is advantageous as it has a long shelf-life, is inexpensive, is quick to make, and is simple to use. Within minutes of mixing the tablet and patient sample, a smartphone camera can scan the sample to determine the type and quantity of HCV. Since there are over 1 billion smartphone users in the world, this diagnostic platform can increase accessibility to medical tests globally. As opposed to sending tests to distant facilities or purchasing expensive equipment, my method requires little user training, has a long shelf life, and costs less than 30 cents per test. Moreover, the design of this diagnostic test can be applied to other infectious diseases, as the rapid identification of infected individuals is essential for containing outbreaks and effectively managing disease.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
377327
Name
Kozlowski Hannah N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Designing a Diagnostic Tablet for Point-of-Care Hepatitis C Virus (HCV) Detection using Quantum Dot Barcodes.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Diagnostics; Hepatitis C; Nanotechnology; Nucleic Acids; Point-Of-Care; Quantum Dots; Storage Capacity; Tablet; Thermal Stability
Abstract
Hepatitis C virus (HCV) can cause chronic hepatitis C, a treatable infectious disease that continues to contribute to liver-related illness and death. In 2011, there were over 245 000 Canadians living with chronic hepatitis C. Unfortunately, only 20% of individuals with HCV are thought to be diagnosed, as access to HCV testing is limited. Standard HCV tests are slow, costly, labour intensive, and require extensive user training, making them unsuitable for use in resource-poor areas where they are needed most critically. Early diagnosis, however, allows patients to prevent complications and obtain treatment earlier. In order to determine which HCV treatment is best suited for a patient, doctors must know the type of HCV causing the infection. Here I propose a design for a low-cost, easy-to-use diagnostic test that can identify the type and quantity of HCV using a single tablet.
In my project I will use nanoparticles, materials 1-100nm in size, to detect different types of HCV. Nanoparticles colour coded for HCV type will be used in combination to identify multiple types of HCV in the same test. These nanoparticles will be encased in a tablet-similar to drug tablets that dissolve in liquids. A tablet is advantageous as it has a long shelf-life, is inexpensive, is quick to make, and is simple to use. Within minutes of mixing the tablet and patient sample, a smartphone camera can scan the sample to determine the type and quantity of HCV. Since there are over 1 billion smartphone users in the world, this diagnostic platform can increase accessibility to medical tests globally. As opposed to sending tests to distant facilities or purchasing expensive equipment, my method requires little user training, has a long shelf life, and costs less than 30 cents per test. Moreover, the design of this diagnostic test can be applied to other infectious diseases, as the rapid identification of infected individuals is essential for containing outbreaks and effectively managing disease.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kozlowski, Hannah N
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~